DK171238B1 - Thymopentin- eller spleninanaloge peptider samt farmaceutisk præparat indeholdende disse - Google Patents

Thymopentin- eller spleninanaloge peptider samt farmaceutisk præparat indeholdende disse Download PDF

Info

Publication number
DK171238B1
DK171238B1 DK289285A DK289285A DK171238B1 DK 171238 B1 DK171238 B1 DK 171238B1 DK 289285 A DK289285 A DK 289285A DK 289285 A DK289285 A DK 289285A DK 171238 B1 DK171238 B1 DK 171238B1
Authority
DK
Denmark
Prior art keywords
asp
val
arg
phe
peptide
Prior art date
Application number
DK289285A
Other languages
Danish (da)
English (en)
Other versions
DK289285A (da
DK289285D0 (da
Inventor
Gideon Goldstein
George Heavner
Daniel Kroon
Tapan Audhya
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK289285D0 publication Critical patent/DK289285D0/da
Publication of DK289285A publication Critical patent/DK289285A/da
Application granted granted Critical
Publication of DK171238B1 publication Critical patent/DK171238B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C07K14/662—Thymopoietins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Charge By Means Of Generators (AREA)
  • Control Of Combustion (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK289285A 1984-06-27 1985-06-26 Thymopentin- eller spleninanaloge peptider samt farmaceutisk præparat indeholdende disse DK171238B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/625,344 US4629723A (en) 1984-06-27 1984-06-27 Potent thymopentin analogs
US62534484 1984-06-27

Publications (3)

Publication Number Publication Date
DK289285D0 DK289285D0 (da) 1985-06-26
DK289285A DK289285A (da) 1985-12-28
DK171238B1 true DK171238B1 (da) 1996-08-05

Family

ID=24505633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK289285A DK171238B1 (da) 1984-06-27 1985-06-26 Thymopentin- eller spleninanaloge peptider samt farmaceutisk præparat indeholdende disse

Country Status (14)

Country Link
US (2) US4629723A (fr)
EP (1) EP0166612B1 (fr)
JP (1) JPH0689029B2 (fr)
KR (1) KR920006563B1 (fr)
AT (1) ATE81135T1 (fr)
AU (1) AU592309B2 (fr)
CA (1) CA1269499A (fr)
DE (1) DE3586697T2 (fr)
DK (1) DK171238B1 (fr)
FI (1) FI92325C (fr)
IL (1) IL75637A (fr)
NO (1) NO167924C (fr)
NZ (1) NZ212461A (fr)
ZA (1) ZA854832B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004334A1 (fr) * 1985-01-18 1986-07-31 MERCK Patent Gesellschaft mit beschränkter Haftung Peptides de regulation immunitaire
DE3619633A1 (de) * 1986-06-11 1987-12-17 Hoechst Ag Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
HUT46044A (en) * 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
WO1989009229A1 (fr) * 1988-03-31 1989-10-05 Immunobiology Research Institute, Inc. Traitement de patient atteint de viremie du hiv a l'aide de thymopentine
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
US4943477A (en) * 1988-09-27 1990-07-24 Mitsubishi Rayon Co., Ltd. Conductive sheet having electromagnetic interference shielding function
KR900701298A (ko) * 1988-09-30 1990-12-01 원본미기재 T-세포 억제작용을 보유한 펩티드
IT1227908B (it) * 1988-12-23 1991-05-14 Eniricerche S P A Milano Sclav Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche
US5218089A (en) * 1988-12-23 1993-06-08 Sclavo S.P.A. Retro-inverso analogues of thymopentin and the method for their synthesis
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
JPH06506918A (ja) * 1991-02-04 1994-08-04 ジヨージ・ワシントン・ユニバーシテイ インターロイキン−１の産生を促進しそして年令−関連性免疫応答を調整するペプチドｍｂ−４
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US5215964A (en) * 1991-06-03 1993-06-01 Immunobiology Research Institute, Inc. Peptides useful in regulating the immune and nervous systems
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
WO1994025482A1 (fr) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides comprenant des groupes contraignant la conformation qui sont adjacents a un site d'interaction proteine-proteine
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺，其药物组合物与用途
CN117860921A (zh) * 2021-12-16 2024-04-12 江西中医药大学 一种胸腺五肽衍生物tp-7在制备肿瘤诊断和/或治疗试剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077949A (en) * 1973-12-28 1978-03-07 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US4261886A (en) * 1980-03-13 1981-04-14 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
ZA802170B (en) * 1979-04-12 1981-11-25 Ortho Pharma Corp Peptides having thymopoietin-like activity
CA1157466A (fr) * 1979-04-12 1983-11-22 Gideon Goldstein Peptides ayant des proprietes ressemblant a celles de la thymopoietine
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
US4305852A (en) * 1980-10-20 1981-12-15 American Home Products Corporation Polypeptide compositions
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
DE3421614A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens

Also Published As

Publication number Publication date
CA1269499A (fr) 1990-05-22
ATE81135T1 (de) 1992-10-15
FI92325B (fi) 1994-07-15
KR860000314A (ko) 1986-01-28
DE3586697D1 (en) 1992-11-05
FI852522L (fi) 1985-12-28
US4629723A (en) 1986-12-16
AU592309B2 (en) 1990-01-11
DE3586697T2 (de) 1993-02-11
AU4421585A (en) 1986-01-02
NO167924C (no) 1991-12-27
JPH0689029B2 (ja) 1994-11-09
JPS6118799A (ja) 1986-01-27
NZ212461A (en) 1988-10-28
IL75637A (en) 1990-02-09
ZA854832B (en) 1987-02-25
EP0166612A2 (fr) 1986-01-02
NO167924B (no) 1991-09-16
NO852567L (no) 1985-12-30
DK289285A (da) 1985-12-28
IL75637A0 (en) 1985-10-31
EP0166612B1 (fr) 1992-09-30
FI92325C (fi) 1994-10-25
USRE34165E (en) 1993-01-19
DK289285D0 (da) 1985-06-26
FI852522A0 (fi) 1985-06-26
KR920006563B1 (ko) 1992-08-08
EP0166612A3 (en) 1987-08-05

Similar Documents

Publication Publication Date Title
DK171238B1 (da) Thymopentin- eller spleninanaloge peptider samt farmaceutisk præparat indeholdende disse
DK167928B1 (da) Enzym-resistente immunomodulatoriske thymopoietin- eller spleninanaloge peptider og deres farmaceutisk acceptable syre- eller baseadditionssalte samt fremgangsmaade til fremstilling deraf
US4547489A (en) Conformationally restricted thymopentin-like compounds
CA1241643A (fr) Peptides influencant la reaction immunulogique et procede de preparation
AU625598B2 (en) Peptides having t cell helper activity
US4116951A (en) [Asn2 ]-thymosin α1 and analogs thereof
US4261886A (en) Peptides having thymopoietin-like activity
US4395404A (en) Synthetic thymosin β3 and β4 analogues
US4215112A (en) Tripeptides and methods
US4081434A (en) Novel analogs of β-endorphin
US3749703A (en) Asn15-bovine thyrocalcitonin
US4397842A (en) Peptides having thymopoietin-like activity
EP0018182B1 (fr) Peptides possédant une activité analogue à celle de la thymopoiétine, compositions pharmaceutiques qui les contiennent, et procédé pour les préparer
EP0361977A2 (fr) Peptides à activité T-cellules suppressives
US4959352A (en) Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
FI96115B (fi) Menetelmä peptidien valmistamiseksi, joilla on T-soluavustaja-aktiivisuutta
JPS62292799A (ja) 新規なペプチド類
Wang et al. [Asn 2]-thymosin α 1 and analogs thereof
Low et al. Synthetic thymosin β 3 and β 4 analogues

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired